Lyra Therapeutics, Inc. — Form D

Lyra Therapeutics, Inc. of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-09. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Michael AltmanDirectorWatertown, MA
Edward AndersonDirectorWatertown, MA
C. Ann MerrifieldDirectorWatertown, MA
Maria Palasis, Ph.D.DirectorWatertown, MA
Konstantin Ann PoukalovDirectorWatertown, MA
W. Bradford SmithDirectorWatertown, MA
Nancy Bradford Snyderman, M.D., FACSDirectorWatertown, MA
James R TobinDirectorMarlton, NJ
Harlan Waksal, M.D.DirectorWatertown, MA
John R Bishop, Ph.D.Executive OfficerWatertown, MA
Jason CavalierExecutive OfficerWatertown, MA
Richard R Nieman, M.D.Executive OfficerWatertown, MA
Maria Palasis, Ph.D.Executive OfficerWatertown, MA
Harlan Waksal, M.D.Executive OfficerWatertown, MA
Robert LangerDirectorPittsburgh, PA
Guido NeelsDirectorTORONTO, A6
Bradford SmithDirectorOttawa, Ontario, Z4
Carmichael RobertsDirectorMALDEN, MA
Maria PalasisDirectorAustin, TX
Maria PalasisExecutive OfficerAustin, TX
Konstantin PoukalovDirectorMarlton, NJ
James GoldsteinDirectorBoston, MA
George WhitesidesDirectorBedford, MA
Terrance McGuireDirectorCambridge, MA
Robert Richard, Ph.D.Executive OfficerWatertown, MA

Other filings by this issuer (12)

FiledFormOfferingSold
2022-04-26D$100.5M$100.5M
2020-01-27D$28.0M$28.0M
2016-11-28D$6.0M$6.0M
2013-04-12D$21.2M$18.0M
2012-10-30D$6.0M$5.1M
2011-11-08D$3.0M$3.0M
2011-09-08D$18.0M$12.0M
2010-08-12D$3.0M$3.0M
2010-05-18D$10.1M$10.1M
2010-03-19D$1.0M$1.0M
2010-01-20D$2.0M$2.0M
2009-04-14D$12.2M$8.2M

More